Last edition
News about "extensive-stage Small Cell Lung Cancer"
Imfinzi-Tarlatamab Combination Improves Overall Survival in Phase 3 ES-SCLC Trial
AstraZeneca and Amgen reported statistically significant improvements in overall and progression-free survival with Imfinzi plus tarlatamab versus Imfinzi alone in the Phase 3 DeLLphi-305 trial.
Extensive-Stage Small Cell Lung Cancer | 10/09/2026 | By News Bureau
SN BioScience Doses First Patient in Phase 1b/2 Clinical Trial of SNB-101
SN BioScience initiates first patient dosing in a global phase 1b/2 trial of SNB-101, a nanoparticle anticancer therapy for Small Cell Lung Cancer (SCLC).
Extensive-stage Small Cell Lung Cancer | 16/05/2026 | By News Bureau | 114
CStone's CS2009 Secures U.S. FDA IND Clearance for Phase II Trial in Advanced Solid Tumours
CStone Pharmaceuticals has received U.S. FDA IND clearance to begin a Phase II trial of its trispecific antibody CS2009 for advanced solid tumours, advancing its global immunotherapy development programme.
Extensive-stage Small Cell Lung Cancer | 16/02/2026 | By News Bureau | 249
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy